MAP4K4 Inhibitors
View/ Open
Date
2020-06-11ICR Author
Author
Newton, G
Schneider, M
Chapman, K
Aqil, R
Jarvis, A
Type
Patent
Metadata
Show full item recordAbstract
This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method of treatmentof cardiac conditions.In particular, the present invention relates to compounds of formula (I):
Collections
Subject
Kinase
Cardiovascular
Research team
Medicinal Chemistry 3
Language
eng
License start date
2020-06-11
Citation
2020